VSIR and non-small cell lung carcinoma: VISTA was identified as a V-set receptor that suppresses T cell-associated response for immune evasion and survival in several human cancers, such as prostate cancer, non-small cell lung cancer (NSCLC), and colorectal carcinoma [13–15].